Similarly, Kiechl et al. found a five-fold increase in breast cancer risk among postmenopausal women with elevated progesterone and RANKL levels, in parallel with changes in the RANK/OPG ratio [50]. Here, TNFRSF11A is linked to breast carcinoma.